MTAR: Mild TBI Assessment & Rehabilitation

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT02920788
Collaborator
(none)
62
1
3
72.7
0.9

Study Details

Study Description

Brief Summary

One of the most pressing concerns within the VA currently is the provision of interventions that address the cognitive as well as emotional problems faced by Veterans with mild TBI and comorbid conditions. When completed, these studies will inform us whether training core attentional self-regulatory control functions via personally-relevant activities will be effective in improving daily life for Veterans with mild TBI and comorbid conditions. The study design will provide a test not only of potential benefits for real life functioning, but also determine to what extent these benefits are related to actual changes in cognitive/behavioral performance and brain networks corresponding to these functions. This project will provide a foundation for future studies to investigate the neural mechanisms that support improvements of cognition and behavior in mTBI.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Goal-Oriented Attentional Self-Regulation (GOALS)
  • Other: Brain Health Education (BHE)
  • Device: fMRI
N/A

Detailed Description

Combat-related mild traumatic brain injury (mTBI) and co-morbid conditions are prevalent in returning Veterans with the reported rates ranging from 14- 22%. Chronic sequela of mTBI can be highly debilitating due to deficits in the cognitive control processes, including attention, executive functions, and memory. In prior studies, individuals with chronic acquired brain injury who participated in a cognitive training program, Goal-Oriented Attentional Self-Regulation (GOALS), which targets executive control functions of applied mindfulness-based attention regulation and goal management, improved cognitive performance in areas of: complex attention/executive function and memory, complex functional task performance, and daily functioning. Furthermore, functional MRI (fMRI) results after training indicated significantly enhanced modulation of neural processing. Preliminary data from recently completed randomized-control GOALS study in 32 Veterans with chronic TBI also show both short and longer term (up to 2 years) improvements in attention and executive function, complex real-life tasks, and emotional regulation.

The primary objectives of this study are to investigate the potential short and longer term effects of GOALS cognitive training program, and to use advanced MRI to investigate changes in brain structure and function in the circuits that regulate attention, memory, executive function and emotion in Veterans with chronic mTBI.

The investigators postulate that 1) GOALS training will improve neurocognitive function in attention and executive function domains, complex functional task performance, and emotional regulation in Veterans with chronic mTBI; 2) improved neurocognitive function will be correlated with macrostructural, microstructural and functional changes in the corresponding brain networks on high field (3T) and ultra-high field (7T) structural MR imaging, diffusion tensor imaging (DTI) and resting state fMRI performed pre- and post-training; 3) Changes in both behavioral function and imaging measures will be maintained at 6 months post-training and be associated with improvements in activities and participation.

AIM 1: To determine the short and long term effects of GOALS training on neuro-cognitive performance and neural plasticity of attention and executive control networks in mTBI.

AIM 2: To determine the short and long term effects of GOALS training on complex functional task performance and daily functioning, and on plasticity in pathways related to memory function, in mTBI.

AIM 3: To determine the short and long term effects of GOALS training on measures of emotional regulation, and on plasticity of frontolimbic networks related to emotion processing, in mTBI In a randomized, controlled interventional study design, 36 Veterans with a history of chronic (> 6 month) mTBI and residual cognitive difficulties will be randomized to participate in 5 weeks of cognitive training (GOALS) or a treatment as usual (TAU) comparison. At baseline, week 5 (post GOALS), and at 6 months, participants will undergo a multi-level assessment battery consisting of: 1) neuroimaging with high field (3T) and ultra-high field (7T) structural MR imaging, diffusion tensor imaging (DTI) and resting state fMRI; 2) neuropsychological assessment focusing on complex attention and executive function; 3) complex 'real life' functional task performance; and 4) self-report measures of daily functioning and emotional regulation/health.

Additionally, the investigators will be recruiting a separate cohort of 15 equally matched healthy veteran volunteers who have no TBI history, for normative comparisons. TBI-negative participants, who will not be participating in training sessions, will have neuroimaging with ultra-high field (7T) structural MR imaging and neuropsychological assessments at baseline and week 5.

When completed, this project will determine whether training core attentional self-regulatory control functions via personally-relevant activities will be effective in improving quality of life and daily functioning for Veterans with mTBI. The study design will provide a test of potential benefits on real-life functioning, and also determine to what extent these benefits are related to actual changes in hypothetically targeted cognitive/behavioral functions and brain networks corresponding to these functions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Multi-Level Assessment and Rehabilitation of Combat Mild TBI
Actual Study Start Date :
Mar 9, 2017
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Veteran Mild TBI Group - GOALS Intervention

Veterans ages 18+ with chronic mild TBI, to undergo GOALS cognitive training as an intervention.

Behavioral: Goal-Oriented Attentional Self-Regulation (GOALS)
GOALS is a manualized, therapist-administered cognitive training program that targets executive control functions of applied mindfulness-based attention regulation and goal management strategies and links them to participant-defined real-life goals. In contrast to training via practice on isolated tasks, this training protocol involves application of attention regulation skills and strategies to participant-defined goals in real life, ecologically valid settings. One of the main training aims is to improve self-regulatory control mechanisms as they contribute to goal attainment.

Device: fMRI
Functional Magnetic Resonance Imaging of the Brain

Active Comparator: Veteran Mild TBI - Treatment as Usual

Veterans ages 18+ with chronic mild TBI, matched by demographic and clinical criteria to the GOALS group, to receive the standard clinical care.

Other: Brain Health Education (BHE)
BHE group is a formal in-person, active, psycho-educational, control intervention closely matched to GOALS for length, intensity, and contact with a therapist/facilitator. Topics include brain structure, function, sleep, stress, emotion and the brain.
Other Names:
  • Treatment As Usual (TAU)
  • Device: fMRI
    Functional Magnetic Resonance Imaging of the Brain

    No Intervention: Veteran Non TBI - No Treatment

    Veterans ages 18+ with no history of TBI, to undergo Neuropsychologic evaluation and MR Imaging with no intervention.

    Outcome Measures

    Primary Outcome Measures

    1. Delis-Kaplan Executive Function System (D-KEFS) Stroop Inhibition-Switching Task [6 months after enrollment]

      Single Test for Attention, Executive Function and Mental Flexibility

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    For TBI-positive veteran participants, to be randomized to either GOALS or TAU:
    • Ages 18+

    • A history of mild TBI (as defined by DOD / VA; confirmed by medical records and in person Ohio State University TBI Instrument)

    • Chronic, stable phase of recovery (>6 months from last post-concussive event)

    • Report of residual cognitive difficulties (1 moderate or severe cognitive symptom(s) on the Neurobehavioral Symptom Inventory (NSI)) that interfere(s) with daily function

    • Able and willing to commit to participate in training and assessments

    • If on psychoactive medications, must be stable on medications (> 30 days)

    For the TBI-negative healthy veteran control group:
    • Ages 18+

    • No history of any (mild to severe) TBI (as defined by DOD / VA; confirmed by medical records and in person Ohio State University TBI Instrument)

    • Able and willing to commit to participate in assessments

    • If on psychoactive medications, must be stable on medications (> 30 days)

    Exclusion Criteria:
    For the TBI-positive veteran participants, to be randomized to either GOALS or TAU:
    • A history of moderate or severe TBI

    • Unstable medical, neurologic, or psychiatric condition, including severe cognitive dysfunction, or other reasons for being unable or unwilling to participate in study procedures (e.g., contraindications to MRI)

    • Ongoing illicit drug or alcohol abuse (AUDIT>8)

    • Psychosis

    • Severe depression, anxiety or PTSD that precludes participation in research activities

    • Poor English comprehension

    • Eligible participants may have other co-morbid stable neuropsychiatric disorders, including depression and PTSD

    • There will be no restriction in regard to gender, race and socioeconomic status

    For the TBI-negative healthy veteran control group:
    • A history of any mild, moderate, or severe TBI

    • Unstable medical, neurologic, or psychiatric condition, including severe cognitive dysfunction, or other reasons for being unable or unwilling to participate in study procedures (e.g. contraindications to MRI)

    • Ongoing illicit drug or alcohol abuse (AUDIT>8)

    • Psychosis

    • Severe depression, anxiety or PTSD that precludes participation in research activities

    • Poor English comprehension

    • Eligible participants may have other co-morbid stable neuropscyhiatric disorders, including depression and PTSD.

    • There will be no restriction in regard to gender, race and socioeconomic status

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Francisco VA Medical Center, San Francisco, CA San Francisco California United States 94121

    Sponsors and Collaborators

    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Pratik Mukherjee, MD PhD, San Francisco VA Medical Center, San Francisco, CA

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT02920788
    Other Study ID Numbers:
    • N2300-R
    First Posted:
    Sep 30, 2016
    Last Update Posted:
    Mar 8, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 8, 2022